Health and Healthcare

AI and nanotechnology could make cancer cell therapy affordable for all

With public-private support CAR-T therapy could have a similar impact on medicine as antibiotics. Image: REUTERS/Peter Nicholls.

Professor Liesbet Lagae

Director of Life Science Technology Activities at IMEC and teaches Nanobiotechnology, KU Leuven

Share:

Our Impact
The Big Picture
Explore and monitor how Health and Healthcare is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Health and Healthcare

Have you read?

Discover

What is the World Economic Forum doing about healthcare value and spending?

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

Health and HealthcareEmerging TechnologiesArtificial IntelligenceGlobal Health

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Monkeypox vaccines: A virologist answers 6 key questions
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum